Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term therapeutic use. Found 398 abstracts

no pagination
Bookman MA. Extending the platinum-free interval in recurrent ovarian cancer: the role of topotecan in second-line chemotherapy. The oncologist. 1999 Jan;4(2):87-94.
Hudes GR, Lipsitz S, Grem J, Morrisey M, Weiner L, Kugler JW, Benson A. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292). Cancer. 1999 Jan 15;85(2):290-4.
Langer CJ. The role of tegafur/uracil in pulmonary malignancy. Drugs. 1999 Jan;58 Suppl 3:71-5.
Movsas B, Scott C, Sause W, Byhardt R, Komaki R, Cox J, Johnson D, Lawton C, Dar AR, Wasserman T, Roach M, Lee JS, Andras E. The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies. Int J Radiat Oncol Biol Phys. 1999 Dec;45(5):1143-9.
Watson JC, Sutanto-Ward E, Osaku M, Weinstein JK, Babb JS, Sigurdson ER. Importance of timing and length of administration of angiogenesis inhibitor TNP-470 in the treatment of K12/TRb colorectal hepatic metastases in BD-IX rats. Surgery. 1999 Aug;126(2):358-63.
Bookman MA. Biological therapy for gynecologic malignancies. Cancer Treat Res. 1998 Jan;95:115-47.
Dresler CM. Kidney metastases. Chest Surg Clin N Am. 1998 Feb;8(1):127-9.
Ozols RF. Chemotherapy of ovarian cancer. Cancer Treat Res. 1998 Jan;95:219-34.
Sokol DB, Hudes GR. Cisplatin-based chemotherapy for testicular cancer in a patient with spinal muscular atrophy: a case report. Am J Clin Oncol. 1998 Aug;21(4):420-1.
Fowble B. Postmastectomy radiation: then and now. Oncology (Huntingt). 1997 Feb;11(2):213-34, 239; discussion 239-40, 243.
Hudes G. Estramustine-based chemotherapy. Semin Urol Oncol. 1997 Feb;15(1):13-9.
Johnson CA, Kilpatrick D, von Roemeling R, Langer C, Graham MA, Greenslade D, Kennedy G, Keenan E, O'Dwyer PJ. Phase I trial of tirapazamine in combination with cisplatin in a single dose every 3 weeks in patients with solid tumors. J Clin Oncol. 1997 Feb;15(2):773-80.
Murphy-Boesch J, Li CW, He L, Padavic-Shaller KA, Negendank W, Brown TR. Proton-decoupled 19F spectroscopy of 5-FU catabolites in human liver. Magn Reson Med. 1997 Mar;37(3):321-6.
Weiner LM, Alpaugh RK, von Mehren M. Redirected cellular cytotoxicity employing bispecific antibodies and other multifunctional binding proteins. Cancer immunology, immunotherapy : CII. 1997 Nov;45(3-4):190-2.
Wilkinson Jt, Clapper ML. Detoxication enzymes and chemoprevention. Proc Soc Exp Biol Med. 1997 Nov;216(2):192-200.
O'Dwyer PJ, Laub PB, DeMaria D, Qian M, Reilly D, Giantonio B, Johnston AL, Wu EY, Bauman L, Clendeninn NJ, Gallo JM. Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusion. Clin Cancer Res. 1996 Oct;2(10):1685-92.
Keller SM. Current and future therapy for malignant pleural effusion. Chest. 1993 Jan;103(1 Suppl):63S-67S.
Blumberg BS, Millman I, Venkateswaran PS, Thyagarajan SP. Hepatitis B virus and primary hepatocellular carcinoma: treatment of HBV carriers with Phyllanthus amarus. Vaccine. 1990 Mar;8 Suppl:S86-92.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term therapeutic use

therapeutic use Human drug therapy Female US Gov't Support-PHS Male Antineoplastic Combined Chemotherapy Protocols Non-US Gov't Support administration & dosage Adult pathology Aged Middle Age Clinical Trials Lung Neoplasms Antineoplastic Agents Cisplatin prevention & control Non-Small-Cell Lung Carcinoma Neoplasms Local Neoplasm Recurrence metabolism surgery therapy Ovarian Neoplasms adverse effects complications secondary pharmacokinetics Fluorouracil Disease-Free Survival Bispecific Antibodies radiotherapy Prospective Studies Combined Modality Therapy Treatment Outcome antagonists & inhibitors chemically induced Risk Factors pharmacology Time Factors Stomatitis Topotecan Fatigue Fever Age Factors Survival Analysis Enzymes blood Disease Progression Rats toxicity 80 and over Aged Imaging Phantoms Area Under Curve Spinal Muscular Atrophy DNA-Directed DNA Polymerase Leucovorin Enzyme Induction Punctures Breast Neoplasms Meta-Analysis Experimental Liver Neoplasms Pleura Carcinogens Agranulocytosis Salvage Therapy Liver Neoplasms dosage Karnofsky Performance Status Animal Disease Models Metabolic Clearance Rate Prostatic Neoplasms IgG Receptors Growth Substances Sesquiterpenes Paclitaxel Liver genetics drug effects Carrier State adverse methods physiopathology Sclerosing Solutions Quality-Adjusted Life Years Adenocarcinoma Hepatitis B virus Immunoglobulin G Hepatocellular Carcinoma Testicular Neoplasms Antineoplastic Antibiotics effects Kidney Neoplasms Prognosis US Gov't Support-Non-PHS Neoplasm Drug Resistance Bilirubin Cultured Tumor Cells Drug Combinations Genetic Engineering Stomach Neoplasms Superantigens immunology Tegafur Interferons instrumentation Case Report Carboplatin Hepatitis B Anticarcinogenic Agents Cytokines Treatment Failure urine enzymology physiology Squamous Cell Carcinoma Interferon-alpha Marmota Alanine Transaminase Immunotherapy Pathologic Neovascularization Magnetic Resonance Spectroscopy Drug Synergism erbB-2 Receptor Hormone-Dependent Neoplasms Drug Metabolic Detoxication Viral Hepatitis-Animal Aspartate Aminotransferases Etoposide Recurrence Neoplasm Staging Vomiting Survival Rate beta-Alanine Female Genital Neoplasms Nausea Antitumor Drug Screening Assays Drainage Enzyme Inhibitors Indoles Plant Extracts Estramustine Drug Administration Schedule Malignant Pleural Effusion analogs & derivatives Germinoma Growth Factor Receptors Triazines Neoplasm Metastasis
Last updated on Friday, January 03, 2020